Henan Taloph Pharmaceutical Stock Co Ltd Financial Flexibility Index
Henan Taloph Pharmaceutical Stock Co Ltd financial flexibility index. Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥28.14 Million (operating CF CN¥22.69 Million minus capex CN¥5.45 Million) represents 0% of total liabilities (CN¥2.09 Billion). See 600222 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Financial flexibility index of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. Check how high is Henan Taloph Pharmaceutical Stock Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Henan Taloph Pharmaceutical Stock Co Ltd Financial Flexibility Index by Year (1998–2025)
Henan Taloph Pharmaceutical Stock Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Henan Taloph Pharmaceutical Stock Co Ltd. For the full cash flow conversion analysis, see Henan Taloph Pharmaceutical Stock Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥68.28 Million | CN¥47.16 Million | CN¥1.98 Billion | ▲ +2831.4% |
| 2024 | 0.00x | CN¥-2.35 Million | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -102.8% |
| 2023 | 0.04x | CN¥86.87 Million | CN¥43.74 Million | CN¥1.95 Billion | ▲ +252.9% |
| 2022 | -0.03x | CN¥-57.78 Million | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -142.1% |
| 2021 | 0.07x | CN¥138.73 Million | CN¥99.66 Million | CN¥2.01 Billion | ▼ -12.0% |
| 2020 | 0.08x | CN¥146.08 Million | CN¥73.43 Million | CN¥1.86 Billion | ▼ -24.8% |
| 2019 | 0.10x | CN¥149.20 Million | CN¥41.53 Million | CN¥1.43 Billion | ▼ -18.8% |
| 2018 | 0.13x | CN¥185.88 Million | CN¥119.47 Million | CN¥1.44 Billion | ▲ +147.8% |
| 2017 | 0.05x | CN¥67.51 Million | CN¥23.17 Million | CN¥1.30 Billion | ▼ -54.1% |
| 2016 | 0.11x | CN¥130.21 Million | CN¥70.60 Million | CN¥1.15 Billion | ▲ +15.9% |
| 2015 | 0.10x | CN¥111.31 Million | CN¥49.27 Million | CN¥1.14 Billion | ▼ -13.8% |
| 2014 | 0.11x | CN¥125.17 Million | CN¥89.54 Million | CN¥1.11 Billion | ▲ +525.0% |
| 2013 | 0.02x | CN¥15.60 Million | CN¥-6.65 Million | CN¥861.22 Million | ▼ -83.8% |
| 2012 | 0.11x | CN¥102.35 Million | CN¥87.45 Million | CN¥912.93 Million | ▲ +44.5% |
| 2011 | 0.08x | CN¥64.52 Million | CN¥105.20K | CN¥831.28 Million | ▲ +634.9% |
| 2010 | 0.01x | CN¥6.78 Million | CN¥-20.00 Million | CN¥641.92 Million | ▼ -89.2% |
| 2009 | 0.10x | CN¥49.70 Million | CN¥21.45 Million | CN¥506.12 Million | ▼ -36.6% |
| 2008 | 0.15x | CN¥59.11 Million | CN¥18.13 Million | CN¥381.43 Million | ▼ -21.4% |
| 2007 | 0.20x | CN¥63.75 Million | CN¥21.34 Million | CN¥323.29 Million | ▲ +66.2% |
| 2006 | 0.12x | CN¥38.23 Million | CN¥1.59 Million | CN¥322.24 Million | ▲ +59.5% |
| 2005 | 0.07x | CN¥20.73 Million | CN¥276.30K | CN¥278.70 Million | ▼ -36.4% |
| 2004 | 0.12x | CN¥33.15 Million | CN¥18.25 Million | CN¥283.44 Million | ▲ +52.1% |
| 2003 | 0.08x | CN¥20.63 Million | CN¥3.74 Million | CN¥268.36 Million | ▲ +47.2% |
| 2002 | 0.05x | CN¥13.82 Million | CN¥7.47 Million | CN¥264.70 Million | ▼ -90.5% |
| 2001 | 0.55x | CN¥113.76 Million | CN¥55.03 Million | CN¥206.07 Million | ▼ -17.7% |
| 2000 | 0.67x | CN¥108.99 Million | CN¥875.36K | CN¥162.45 Million | ▼ -43.4% |
| 1999 | 1.19x | CN¥179.18 Million | CN¥99.32 Million | CN¥151.10 Million | ▲ +596.0% |
| 1998 | 0.17x | CN¥28.08 Million | CN¥28.04 Million | CN¥164.79 Million | — |